Vitamin D Level in Recurrent PV

N/AUnknownNCT05067699

Kasr El Aini Hospital200 enrolled

Overview

Serum Samples will be taken from patients with recurrent Pityriasis Versicolor for the evaluation of vitamin D level.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Recurrent Pityriasis Versicolor

Interventions

Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)DIAGNOSTIC_TEST

The serum will be tested by a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human 25Dihydroxy vitamin D（25-OH-D).

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * \- Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it. * Patients of both genders. * Age ≥18 years old. Exclusion Criteria: * \- Patients with other cutaneous diseases. * Patient's having dandruff (scaly scalp) even if not symptomatizing. * Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects. * Patients with autoimmune diseases. * Patients with immunodeficiency diseases. * Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone.

Locations (1)

Kasr Al Ainy Teaching Hospital

Cairo, Egypt

RECRUITING

Outcomes

Primary Outcomes

Serum 25(OH) D3 level

The serum of patients and controls will be tested by a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human 25Dihydroxy vitamin D（25-OH-D).

Time frame: 6months-1 year

Central Contacts

Rana Hilal, M.D

CONTACT

+201001488869 rana.hilal@kasralainy.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.